Comprehensive immunohistochemical analysis based on the origin of leiomyosarcoma

Area of Science:

• Oncology
• Pathology
• Immunohistochemistry

Background:

• Leiomyosarcomas (LMS) exhibit diverse biological behavior and treatment responses based on tumor origin.
• Distinguishing between uterine and extra-uterine LMS is crucial for effective patient management, particularly for tumors in the peritoneum and retroperitoneum.

Purpose of the Study:

• To investigate the immunophenotypic characteristics of uterine and extra-uterine LMS using a comprehensive antibody panel.
• To determine if specific immunophenotypic markers can differentiate between these two LMS subtypes.

Main Methods:

• An immunohistochemical study was conducted on 29 uterine and 42 extra-uterine primary LMS samples.
• A tissue microarray method was employed using 20 antibodies, including estrogen receptor, progesterone receptor (PR), WT-1, SMA, desmin, caldesmon, and others.
• Staining results were evaluated to compare marker expression between uterine and extra-uterine LMS.

Main Results:

• Uterine LMS showed higher staining rates for estrogen receptor (48% vs. 12%), PR (62% vs. 21%), desmin (79% vs. 50%), and EMMPRIN (69% vs. 45%) compared to extra-uterine LMS.
• Extra-uterine LMS exhibited higher staining for caldesmon (88% vs. 69%), c-Myc (33% vs. 10%), and cyclin D1 (52% vs. 28%) than uterine LMS (p < 0.05).
• No significant differences were observed for other tested antibodies.

Conclusions:

• Specific antibodies, including estrogen receptor, PR, desmin, EMMPRIN, caldesmon, c-Myc, and cyclin D1, may assist in determining the primary origin of leiomyosarcomas.
• Immunophenotypic analysis provides valuable insights into the differences between uterine and extra-uterine LMS, potentially guiding clinical decisions.